Skip to main content

Urosepsis

  • Chapter

Part of the book series: Monographies en urologie ((MONOGRAPHIES))

Abstrait

L’urosepsis regroupe les infections urinaires entraînant une réponse inflammatoire systémique. Ce terme sous-entend le plus souvent un élément de gravité. Il représente de 10 à 20 % des cas de sepsis en général, dont l’incidence annuelle est estimée à 240 cas pour 100 000 habitants. Il touche essentiellement la personne de plus de 50 ans sans prédominance de sexe.

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Northeast health care quality foundation, Urosepsis. Coding and DRG notes 2003

    Google Scholar 

  2. Kunin CM (2003) Definition of acute pyelonephritis vs the urosepsis syndrome. Arch Intern Med. 163(19): 2393; author reply 2393–4

    Article  PubMed  Google Scholar 

  3. Bone RC et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6): 1644–1655

    PubMed  CAS  Google Scholar 

  4. Martin GS et al. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348(16): 1546–1554

    Article  PubMed  Google Scholar 

  5. Brun-Buisson C et al. (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. Jama 274(12): 968–974

    Article  PubMed  CAS  Google Scholar 

  6. Brun-Buisson C, Doyon F, Carlet J (1996) Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med 154(3 Pt 1): 617–624

    PubMed  CAS  Google Scholar 

  7. Sands KE et al. (1997) Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group. Jama 278(3): 234–240

    Article  PubMed  CAS  Google Scholar 

  8. Paradisi F, Corti G, Mangani V (1998) Urosepsis in the critical care unit. Crit Care Clin 14(2): 165–180

    Article  PubMed  CAS  Google Scholar 

  9. Alberti C et al. (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28(2): 108–121

    Article  PubMed  Google Scholar 

  10. Angus DC et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7): 1303–1310

    Article  PubMed  CAS  Google Scholar 

  11. Brun-Buisson C et al. (2004) Episepsis: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30(4): 580–588

    Article  PubMed  CAS  Google Scholar 

  12. Stamm WE, Norrby SR (2001) Urinary tract infections: disease panorama and challenges. J Infect Dis 183 Suppl 1: S1–4

    Article  PubMed  Google Scholar 

  13. Carson C, Naber KG (2004) Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections. Drugs 64(12): 1359–1373

    Article  PubMed  CAS  Google Scholar 

  14. Melekos MD, Naber KG (2000) Complicated urinary tract infections. Int J Antimicrob Agents 15(4): 247–256

    Article  PubMed  CAS  Google Scholar 

  15. Stamm WE (2002) Scientific and clinical challenges in the management of urinary tract infections. Am J Med 113 Suppl 1A: 1S–4S

    Article  PubMed  Google Scholar 

  16. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348(2): 138–150

    Article  PubMed  CAS  Google Scholar 

  17. Stamm WE (2003) Urinary tract infections. Infect Dis Clin North Am 17(2): 13–14

    Article  Google Scholar 

  18. Stamm WE (1992) Criteria for the diagnosis of urinary tract infection and for the assessment of therapeutic effectiveness. Infection. 20 Suppl 3: S151–S154 discussion S160–1

    Article  PubMed  Google Scholar 

  19. Société franÇaise d’anesthésie et de réanimation, Antibiothérapie probabiliste des états infectieux graves. in conférence de consensus (2004) Paris

    Google Scholar 

  20. Stamm WE and TM Hooton (1993) Management of urinary tract infections in adults. N Engl J Med 329(18): 1328–1334

    Article  PubMed  CAS  Google Scholar 

  21. Bernard GR (2003) Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis. Crit Care Med 31(1 Suppl): p. S85–S93

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Revest, M., Tattevin, P. (2007). Urosepsis. In: Les infections urinaires. Monographies en urologie. Springer, Paris. https://doi.org/10.1007/978-2-287-48617-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-48617-3_12

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-25172-6

  • Online ISBN: 978-2-287-48617-3

Publish with us

Policies and ethics